NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I think you're being overly pessimistic. As I read it, if the company in the TLD commits to the submission of a BLA, over 80% of the time they're being approved. I do believe we'll get that commitment either in the TLD, or in the company's discussion of the future once the TLD is filed.

We'll learn much more about the trial details once the data's been peer reviewed, and it can be discussed with investors, but I believe we'll have a commitment to submit a BLA before that time.

In that practically nothing is working for GBM, I'd say our odds are better than the 80+% shown in the data for oncology products from BLA to approval.

Gary